The interaction of cytokines in regulating oestradiol 17β-hydroxysteroid dehydrogenase activity in MCF-7 cells

https://doi.org/10.1016/0960-0760(94)90301-8Get rights and content

Abstract

Oestradiol 17γ-hydroxysteroid dehydrogenase (E2DH) has a pivotal role in the regulation of oestradiol (E2) concentrations in normal and amlignant breast tissues. previous studies have suggested that a number of cytokines can stimulate E2DH activity to increase the conversion of oestrone (E1 to E2. In this investigation we have examined the effect of TNFα, interleukin-1β (IL-1β) and IL-6 on E2DH activity in MCF-7 breast cancer cells. These cytokines may produced by breast tumours and their presence in conditioned medium (CM) from tumour-derived fibroblasts was also measured to assess their possible contribution to its E2DH stimulatory activity. Treatment of MCF-7 cells with IL-1β and TNFα (5 ng/ml) significantly increased (P < 0.001) reductive E2DH (red-E2DH, the conversion of E1 to E2) activity. In contrast, IL-6 at a concentration of 100 ng/ml produced little, if any, stimulation of reductive activity. Combinations of all three cytokines acted synergistically to stimulate red-E2DH activity. No cytokine, either alone or in combination, affected oxidative (E2åE1) activity. Significant concentrations of IL-6 and IL-1β were detected in CM, but the stimulation of red-E2DH activity was much greater than that which could be explained by their levels alone. It is concluded that these cytokines may play an important role in regulating E2DH activity in breast cancer cells and may act synergistically in vivo to enhance the formation of E2 in breast tumours.

References (24)

  • E.F. Adams et al.

    Interleukin 6 is secreted by breast fibroblasts and stimulates 17β-oestradiol oxidoreductase activity of MCF-7 cells: possible paracrine regulation of breast 17β-oestradiol levels

    Int. J. Cancer

    (1991)
  • B.J. Sugarman et al.

    Recombinant human tumour necrosis factor-α: effects on proliferation of normal and tranformed cells in vitro

    Science

    (1985)
  • Cited by (62)

    • Role of hydroxysteroid (17beta)dehydrogenase type 1 in reproductive tissues and hormone-dependent diseases

      2019, Molecular and Cellular Endocrinology
      Citation Excerpt :

      Similarly, many factors that stimulate breast cancer proliferation, including IL1 and TNFA, also upregulate HSD17B1 expression in breast cancer cells (Nagasaki et al., 2009) (Table 4). Furthermore, various other cytokines and growth factors, such as IGF1 and 2, IL6 and IL1B, typically produced by inflammatory cells and adipocytes, have been shown to induce E1 to E2 activity in breast cancer cells (Adams et al., 1991; Singh and Reed, 1991; Speirs et al., 1993; Duncan et al., 1994; Duncan and Reed, 1995), suggesting that the inflammation process in breast tumors enhances the tumor-acquired estrogen biosynthesis ability. Furthermore, E1 to E2 activity was increased in breast fibroadenomas in the luteal phase compared to follicular phase and in patients using oral progestins (Fournier et al., 1982), suggesting a role for progestins in the regulation of HSD17B1, an action also shown in breast cancer cells in vitro (Poutanen et al., 1990).

    • HSD17B1 expression enhances estrogen signaling stimulated by the low active estrone, evidenced by an estrogen responsive element-driven reporter gene in vivo

      2015, Chemico-Biological Interactions
      Citation Excerpt :

      Similarly to P450 aromatase (CYP19A1), the expression of HSD17B1 is related to follicular differentiation and positively correlates with the follicular E2 concentration. Granulosa cells of developing and luteinizing follicles express HSD17B1 [27], and various factors that enable the antral-to-preovulatory transition of follicles, including FSH, LH, GH, IGF1, EGF, TGFα, FGF2 and IL1B [28], also up-regulate HSD17B1 expression [29–34]. Of ovarian cancers, the vast majority (80–90%) is derived from the ovarian surface epithelium, and epidemiological evidence suggests that steroid hormones, especially estrogens and progestins, are implicated in ovarian carcinogenesis [35].

    • Estradiol regulates Tumor Necrosis Factor-α expression and secretion in Estrogen Receptor positive breast cancer cells

      2014, Molecular and Cellular Endocrinology
      Citation Excerpt :

      TNFα maintains these surrounding fibroblasts in an undifferentiated state, thus maintaining their estrogen-producing capacity (Zhang et al., 1996). TNFα is also critical in regulating the expression and activity of key enzymes involved in the estrogen biosynthesis pathway, therefore increases in TNFα signalling to surrounding fibroblasts results in a net increase in estrogen levels within the breast tumor microenvironment (Purohit et al., 1996; Duncan et al., 1994; Zhao et al., 1997). In turn, we have shown that estrogen may then upregulate transcript and secreted levels of TNFα in ER+ breast tumor cells.

    View all citing articles on Scopus
    View full text